Senseonics HoldingsSENS +1.13%60 Net Current Asset Value is $0.57 as of Mar. 2026, which is 95% below its 10-year median of 10.96. GuruFocus rates SENS with a GF Score™ of 60/100 and a GF Value™ of $14.24 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 569 Medical Devices & Instruments companies, Senseonics Holdings ranks worse than 71.7% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Senseonics Holdings's net current asset value per share for the quarter that ended in Mar. 2026 was $0.57.
The historical rank and industry rank for Senseonics Holdings's Net Current Asset Value or its related term are showing as below:
SENS'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.35 Med: 10.96 Max: 130
Current: 9.42
During the past 12 years, the highest Price-to-Net-Current-Asset-Value Ratio of Senseonics Holdings was 130.00. The lowest was 4.35. And the median was 10.96.
SENS's Price-to-Net-Current-Asset-Value is ranked worse than 71.7% of 569
companies
in the Medical Devices & Instruments industry
Industry Median: 4.99
vs SENS: 9.42
Senseonics Holdings (NAS:SENS) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Senseonics Holdings Net Current Asset Value Related Terms
Senseonics Holdings Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Senseonics Holdings's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SENS vs LAB, TMCI, SGHT: Net Current Asset Value Comparison
For the Medical Devices subindustry, Senseonics Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Senseonics Holdings Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Senseonics Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Senseonics Holdings's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.57 mean?
Senseonics Holdings (SENS) has a Net Current Asset Value of $0.57 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Senseonics Holdings and its competitors. This is 95% below median its historical median of 10.96. Over the past decade, Senseonics Holdings' Net Current Asset Value has ranged from 4.35 to 130.00. According to the industry distribution chart, Senseonics Holdings ranks #408 out of 569 companies in the Medical Devices & Instruments industry, placing it in the top 71.7%.
Is Senseonics Holdings' Net Current Asset Value too high?
Senseonics Holdings' current Net Current Asset Value of $0.57 is 95% below median its 10-year median of 10.96. Over the past 10 years, this metric has ranged from a low of 4.35 to a high of 130.00. The Medical Devices & Instruments industry median Net Current Asset Value is 4.99. Senseonics Holdings' value of $0.57 is 88.6% below this industry median. Based on the distribution chart, Senseonics Holdings ranks #408 out of 569 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Senseonics Holdings has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Senseonics Holdings' Net Current Asset Value compare to LAB and TMCI?
According to the Medical Devices & Instruments industry distribution chart, Senseonics Holdings ranks #408 out of 569 companies for Net Current Asset Value. This places Senseonics Holdings in the lower half of its industry. The industry median Net Current Asset Value is 4.99. Senseonics Holdings' value of $0.57 is 88.6% below this benchmark. Historically, Senseonics Holdings' own Net Current Asset Value has ranged from 4.35 to 130.00 over the past decade. While the company's 10-year median is 10.96 vs. the industry median of 4.99, Senseonics Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 4.99, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Senseonics Holdings's current Net Current Asset Value of $0.57 is 88.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Senseonics Holdings and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 4.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Senseonics Holdings's current Net Current Asset Value is $0.57, which is 95% below median its own 10-year median of 10.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Senseonics Holdings stock overvalued right now?
Based on GuruFocus' analysis, Senseonics Holdings (SENS) is currently considered Possible Value Trap. The stock's GF Value™ is $14.24, compared to a current price of $5.37 — trading 62.3% below its estimated fair value. The current Net Current Asset Value is $0.57, which is 95% below median its 10-year median of 10.96 and 88.6% below the Medical Devices & Instruments industry median of 4.99. Senseonics Holdings' overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Senseonics Holdings (SENS), the current Net Current Asset Value is $0.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Senseonics Holdings (SENS) Overvalued in 2026?
Based on GuruFocus' analysis, Senseonics Holdings stock appears to be undervalued.
The current stock price of $5.37 is trading 62.3% below its estimated GF Value™ of $14.24.
GuruFocus considers Senseonics Holdings to be Possible Value Trap.
Key valuation signals for SENS:
Net Current Asset Value: $0.57 (95% below median its 10-year median of 10.96)
GF Value™: $14.24 vs. price of $5.37 (62.3% below fair value)
Industry Position: 88.6% below the Medical Devices & Instruments median (#408 of 569)
No single metric tells the full story. See the SENS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.
60GF Score
Get the complete analysis for SENS
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SENS has been successfully added to your 
